As of December 31, 2025, REMEGEN (09995) announced that it had not yet initiated a share repurchase. The company intends to execute the buyback at an opportune time based on market conditions during the repurchase period and will promptly fulfill its information disclosure obligations in accordance with the progress of the share repurchase activities. This update on the repurchase progress is in full compliance with relevant laws, regulations, and the requirements of the company's repurchase plan.